Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin.

CONCLUSIONS: DUSP4 might represent a potential drug target for inhibiting drug resistance and regulating the process of the EMT during the treatment of breast cancer.
PMID: 24012960 [PubMed - as supplied by publisher]

Source: Experimental Cell Research - September 3, 2013 Category: Cytology Authors: Liu Y, Du F, Chen W, Yao M, Lv K, Fu P Tags: Exp Cell Res Source Type: research